- Home
- KRMD
as 07-26-2024 4:00pm EST
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | MAHWAH |
| Market Cap: | 114.4M | IPO Year: | N/A |
| Target Price: | $3.70 | AVG Volume (30 days): | 248.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.98 - $3.12 | Next Earning Date: | 08-07-2024 |
| Revenue: | $29,322,859 | Revenue Growth: | 0.96% |
| Revenue Growth (this year): | 13.58% | Revenue Growth (next year): | 17.19% |
Stock Insider Trading Activity of KORU Medical Systems Inc. (DE) (KRMD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Manko Joseph M. Jr. | KRMD | Director10% Owner | Dec 13 '23 | Buy | $2.40 | 145,833 | $349,999.20 | 7,609,751 | SEC Form 4 |
| Manko Joseph M. Jr. | KRMD | Director10% Owner | Dec 13 '23 | Sell | $2.40 | 145,833 | $349,999.20 | 2,198,825 | SEC Form 4 |
Latest KORU Medical Systems Inc. (DE) News
KRMD Breaking Stock News: Dive into KRMD Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
Simply Wall St.
a day ago
KORU Medical Systems, Inc. (NASDAQ:KRMD) is definitely on the radar of institutional investors who own 33% of the company
Business Wire
2 days ago
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
Business Wire
9 days ago
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
Business Wire
25 days ago
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
Business Wire
2 months ago
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
Business Wire
2 months ago
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
Business Wire
2 months ago
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
Compare KRMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KRMD KORU Medical Systems Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.